ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/12/18 | 2,466 | 2,485 | 2,404 | 2,407 | -48 | -2% | 53,400 |
2024/12/17 | 2,473 | 2,505 | 2,452 | 2,455 | -12 | -0.5% | 60,400 |
2024/12/16 | 2,450 | 2,473 | 2,426 | 2,467 | +16 | +0.7% | 28,400 |
2024/12/13 | 2,400 | 2,455 | 2,400 | 2,451 | +16 | +0.7% | 66,400 |
2024/12/12 | 2,440 | 2,444 | 2,410 | 2,435 | +9 | +0.4% | 39,600 |
2024/12/11 | 2,424 | 2,443 | 2,401 | 2,426 | +2 | +0.1% | 33,800 |
2024/12/10 | 2,457 | 2,479 | 2,420 | 2,424 | -11 | -0.5% | 57,700 |
2024/12/09 | 2,405 | 2,448 | 2,395 | 2,435 | +39 | +1.6% | 87,400 |
2024/12/06 | 2,362 | 2,396 | 2,362 | 2,396 | +40 | +1.7% | 54,100 |
2024/12/05 | 2,343 | 2,364 | 2,329 | 2,356 | +13 | +0.6% | 30,500 |
2024/12/04 | 2,362 | 2,368 | 2,323 | 2,343 | -31 | -1.3% | 38,800 |
2024/12/03 | 2,330 | 2,383 | 2,315 | 2,374 | +51 | +2.2% | 58,300 |
2024/12/02 | 2,350 | 2,350 | 2,288 | 2,323 | -2 | -0.1% | 48,100 |
2024/11/29 | 2,308 | 2,339 | 2,297 | 2,325 | +33 | +1.4% | 70,300 |
2024/11/28 | 2,257 | 2,292 | 2,254 | 2,292 | +54 | +2.4% | 43,200 |
2024/11/27 | 2,251 | 2,262 | 2,225 | 2,238 | -19 | -0.8% | 31,700 |
2024/11/26 | 2,241 | 2,260 | 2,234 | 2,257 | +16 | +0.7% | 34,900 |
2024/11/25 | 2,270 | 2,274 | 2,241 | 2,241 | -3 | -0.1% | 60,800 |
2024/11/22 | 2,239 | 2,252 | 2,222 | 2,244 | +23 | +1% | 37,100 |
2024/11/21 | 2,238 | 2,247 | 2,221 | 2,221 | +5 | +0.2% | 24,500 |
2024/11/20 | 2,222 | 2,236 | 2,215 | 2,216 | ±0 | ±0% | 29,900 |
2024/11/19 | 2,226 | 2,227 | 2,210 | 2,216 | ±0 | ±0% | 23,100 |
2024/11/18 | 2,203 | 2,236 | 2,203 | 2,216 | -13 | -0.6% | 27,600 |
2024/11/15 | 2,256 | 2,256 | 2,220 | 2,229 | -2 | -0.1% | 26,600 |
2024/11/14 | 2,260 | 2,265 | 2,231 | 2,231 | -29 | -1.3% | 37,800 |
2024/11/13 | 2,236 | 2,271 | 2,230 | 2,260 | +20 | +0.9% | 61,100 |
2024/11/12 | 2,229 | 2,258 | 2,229 | 2,240 | +19 | +0.9% | 54,900 |
2024/11/11 | 2,217 | 2,230 | 2,203 | 2,221 | +4 | +0.2% | 46,000 |
2024/11/08 | 2,274 | 2,279 | 2,204 | 2,217 | -38 | -1.7% | 91,700 |
2024/11/07 | 2,239 | 2,298 | 2,221 | 2,255 | -117 | -4.9% | 229,100 |
2024/11/06 | 2,372 | 2,397 | 2,348 | 2,372 | -3 | -0.1% | 95,200 |
2024/11/05 | 2,315 | 2,411 | 2,297 | 2,375 | +71 | +3.1% | 209,900 |
2024/11/01 | 2,315 | 2,330 | 2,294 | 2,304 | -26 | -1.1% | 44,300 |
2024/10/31 | 2,341 | 2,360 | 2,313 | 2,330 | +4 | +0.2% | 77,300 |
2024/10/30 | 2,343 | 2,347 | 2,316 | 2,326 | +4 | +0.2% | 283,300 |
2024/10/29 | 2,308 | 2,339 | 2,300 | 2,322 | +14 | +0.6% | 50,300 |
2024/10/28 | 2,288 | 2,318 | 2,287 | 2,308 | +20 | +0.9% | 31,600 |
2024/10/25 | 2,319 | 2,319 | 2,276 | 2,288 | -26 | -1.1% | 39,600 |
2024/10/24 | 2,302 | 2,323 | 2,292 | 2,314 | +2 | +0.1% | 37,500 |
2024/10/23 | 2,305 | 2,326 | 2,303 | 2,312 | +1 | ±0% | 36,500 |
2024/10/22 | 2,326 | 2,337 | 2,311 | 2,311 | -15 | -0.6% | 39,200 |
2024/10/21 | 2,360 | 2,360 | 2,326 | 2,326 | -22 | -0.9% | 27,800 |
2024/10/18 | 2,333 | 2,354 | 2,326 | 2,348 | +23 | +1% | 32,500 |
2024/10/17 | 2,360 | 2,369 | 2,321 | 2,325 | -30 | -1.3% | 38,400 |
2024/10/16 | 2,340 | 2,369 | 2,337 | 2,355 | +5 | +0.2% | 47,700 |
2024/10/15 | 2,357 | 2,357 | 2,335 | 2,350 | +11 | +0.5% | 44,500 |
2024/10/11 | 2,360 | 2,361 | 2,329 | 2,339 | -18 | -0.8% | 49,300 |
2024/10/10 | 2,350 | 2,357 | 2,331 | 2,357 | +20 | +0.9% | 34,300 |
2024/10/09 | 2,350 | 2,360 | 2,331 | 2,337 | -5 | -0.2% | 55,900 |
2024/10/08 | 2,323 | 2,348 | 2,314 | 2,342 | +4 | +0.2% | 60,200 |
151~
200
件表示中 / 3754件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 211,700円 | +3.1% | -6.5% | 2.27% | 9.82倍 | 1.04倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 279,200円 | +21.7% | +999.9% | 0.00% | 11.71倍 | 3.87倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 323,000円 | +5.1% | -7.0% | 2.48% | 21.20倍 | 0.88倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 154,300円 | -2.4% | -52.3% | 3.69% | 18.47倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 223,600円 | +4.1% | -3.1% | 2.59% | 19.42倍 | 1.69倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム